Biogen (NASDAQ: BIIB) reported better-than-expected fourth-quarter results to see its shares trade modestly higher in pre-market Wednesday.The company reported Q4 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE